"Glaxosmithkline" paid $ 3 billion to settle drug scandal

To is invalid
Parameter name: to
Treatment of diabetes "Avandia" referred to in a real estate scam

Approved pharmaceutical company "glaxosmithkline (GSK) to pay three billion dollars in to count the largest settlement for fraud in health care in the history of the United States.

Pharmaceutical industry company acknowledged guilt in their promotion giant for two properties in therapeutic use not yet approved, and failing to provide safety information on its property for treatment of diabetes medication management and nutrition (FDA).

Judicial settlement include criminal fines and civil settlement with federal and State authorities.

The case concerned the "real estate" and "Wellbutrin Paxil and Avandia" newest company.

He said District Attorney James Cole told a press conference in Washington d.c. that the adjustment was unprecedented in size and scope.

The company found guilty of offering bribes to doctors

Recognized company that is one of the largest health care companies and pharmaceuticals it promoted the use of medication "Paxil" and "Wellbutrin" anti depression uses didn't get approval, including treatments for children and adolescents.

The company also approved charges on hiding information and provide unreliable safety data on diabetes drug "Avandia".

Furthermore the Court found the company guilty of offering bribes to doctors in that regard.

The representative of the public prosecutor Carmen Ortiz, u.s. that company sales department to describe corrupt doctors Akai products for their patients by using various inducements paid them money is huge, ranging from financing trips to Hawaii and push recreation millions of dollars for doctors to do the rounds to talk about their products, so buy cards concerts singers celebrities like Madonna.

In terms of judicial settlement, the company agreed to stay under the control of the Government officials for five years.

The company said in a statement that it would pay the fines imposed on them which available liquidity sources.

Andrew Witty, CEO of the company that is changing the responsible in marketing and sales at the company's branch in the United States.

Witty said "we have learned from the mistakes that we made them, and may remove officials involved in misconduct, when necessary".

View the original article here

Microsoft devalue "aQuantive" by $ 6.2 billion

To is invalid
Parameter name: to
There were expectations that Microsoft profit of 5.25 billion dollars

Microsoft has reduced the value of electronic advertising company "aQuantive", purchased five years ago, in the amount of $ 6.2 billion.

Microsoft bought aQuantive Inc. for $ 6.3 billion in cash as part of its rival "Google" to increase revenue from ads linked to searches on the Internet.

And not to reduce the value of the company's significant impact on Microsoft's shares during the trading day Monday.

Like Microsoft's acquisition of aQuantive "" 2007 the largest takeover by a company, even bought the "Scape" last year compared to $ 8.6 billion.

A statement from Microsoft "has not brought the acquisition of growth rates expected degree."

Analysts believe that the devaluation "aQuantive" comes as no surprise to investors.

Likely to reduce fourth quarter profits of the company very much.

And there were expectations on Wall Street that Microsoft net profits of about $ 5.25 billion on 19 July.

Microsoft pointed out that profit growth forecast in its electronic services — which include search engine "bing" and "MSN Internet portal" – will be less than previous estimates.

View the original article here